NEW ORLEANS – The 18-month results of the MAHALO study demonstrate a positive treatment effect of a complement inhibitor in AMD-related geographic atrophy, according to a speaker here. “The MAHALO results suggest the CFI biomarker is both prognostic for geographic atrophy progression and predictive for lampalizumab treatment response,” Carl D. Regillo, MD, FACS, said at Retina Subspecialty Day preceding the American Academy of Ophthalmology meeting.
Status: Completed,
Condition Summary: Dysthyroid Orbitopathy
NEW ORLEANS – The American Academy of Ophthalmology’s Intelligent Research in Sight Registry is a useful tool for managing the difficulty cornea and external disease practices may face in the wake of the Affordable Care Act, according to a speaker here. “Simplify where possible,” David B. Glasser, MD, said here at Cornea Subspecialty Day preceding the American Academy of Ophthalmology meeting. “The academy’s IRIS [Intelligent Research in Sight] Registry is a great way to do that if you’ve got a long-term health record.”
NEW ORLEANS – In cases of primary angle closure glaucoma, phacoemulsification alone may be considered in eyes with mild degree of angle closure, one surgeon told colleagues here. “I ask myself: Is there a significant cataract? If yes, I consider phaco,” Tin Aung FRCS, PhD, told colleagues at Glaucoma Subspecialty Day preceding the American Academy of Ophthalmology meeting. Basing his presentation on a review of peer-reviewed published literature, Aung said that phacoemulsification alone is generally effective in improving IOP control. Adding trabeculectomy lowers IOP and results in the need for (Read more...)
NEW ORLEANS — Phacoemulsification reduces IOP in glaucomatous and non-glaucomatous eyes, although clinicians are not certain about the underlying causes, a surgeon said here. During Glaucoma Subspecialty Day preceding the American Academy of Ophthalmology meeting, Douglas J. Rhee, MD, OSN Glaucoma Board Member, discussed theories that may explain how phacoemulsification reduces IOP. “The conventional wisdom had been that pressure is usually reduced by about 1 mm Hg to 4 mm Hg, and this can be sustained for about 3 to 5 years,” Rhee said.
NEW ORLEANS — Combined phacoemulsification and angle surgery with a microstent improves safety and clinical outcomes in glaucoma surgery, a speaker told colleagues here. Ike K. Ahmed, MD, FRCSC, elucidated three surgical pearls for the combined procedure during Glaucoma Subspecialty Day preceding the American Academy of Ophthalmology meeting. “Phacoemulsification is a platform for improving aqueous outflow,” Ahmed said. “The premise of microstenting is really based on safety, establishing and re-establishing physiologic outflow and, of course, utilizing flow to prevent hypotony. … This is designed to be a very complex procedure (Read more...)